Simultaneous Analysis of Multiple Monoclonal Antibody Biotherapeutics by LC-MS/MS Method in Rat Plasma Following Cassette-Dosing

详细信息    查看全文

• 作者：Hongyan Li (1)
  Robert Ortiz (1)
  Linh T. B. Tran (1)
  Hossein Salimi-Moosavi (1)
  Jennifer Malella (1)
  Christopher A. James (1)
  Jean W. Lee (1)
  
• 关键词：cassette dosing of biologics ; immunoaffinity ; mass spectrometry ; ligand binding assay ; monoclonal antibody biotherapeutics ; multi ; analyte LC ; MS/MS
• 刊名：The AAPS Journal
• 出版年：2013
• 出版时间：April 2013
• 年：2013
• 卷：15
• 期：2
• 页码：337-346
• 全文大小：611KB
• 参考文献：1. Dubois M, Becher F, Herbet A, Ezan E. Immuno-mass spectrometry assay of EPI-HNE4, a recombinant protein inhibitor of human elastase. Rapid Comm Mass Spectrom. 2007;21(3):352-. CrossRef
  2. Dubois M, Fenaille F, Clement G, Lechmann M, Tabet JC, Ezan E, / et al. Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. Anal Chem. 2008;80(5):1737-5. CrossRef
  3. Ezan E, Dubois M, Becher F. Bioanalysis of recombinant proteins and antibodies by mass spectrometry. Analyst. 2009;134(5):825-4. CrossRef
  4. Hagman C, Ricke D, Ewert S, Bek S, Falchetto R, Bitsch F. Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry. Anal Chem. 2008;80(4):1290-. CrossRef
  5. Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, / et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal Chem. 2008;80(11):4200-. CrossRef
  6. Liu H, Manuilov AV, Chumsae C, Babineau ML, Tarcsa E. Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography-mass spectrometry. Anal Biochem. 2011;414(1):147-3. CrossRef
  7. Li H, Ortiz R, Tran L, Hall M, Spahr C, Walker K, / et al. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal Chem. 2012;84(3):1267-3. CrossRef
  8. Hall MP, Gegg C, Walker K, Spahr C, Ortiz R, Patel V, / et al. Ligand-binding mass spectrometry to study biotransformation of fusion protein drugs and guide immunoassay development: strategic approach and application to peptibodies targeting the thrombopoietin receptor. AAPS J. 2010;12(4):576-5. CrossRef
  9. Bayliss MK, Frick LW. High-throughput pharmacokinetics: cassette dosing. Curr Opin Drug Discov Dev. 1999;2(1):20-.
  10. Manitpisitkul P, White RE. Whatever happened to cassette-dosing pharmacokinetics? Drug discov today. 2004;9(15):652-. CrossRef
  11. Korfmacher WA, Cox KA, Ng KJ, Veals J, Hsieh Y, Wainhaus S, / et al. Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Comm Mass Spectrom. 2001;15(5):335-0. CrossRef
  12. Liu B, Chang J, Gordon WP, Isbell J, Zhou Y, Tuntland T. Snapshot PK: a rapid rodent / in vivo preclinical screening approach. Drug discov today. 2008;13(7-):360-. CrossRef
  13. Nagilla R, Nord M, McAtee JJ, Jolivette LJ. Cassette dosing for pharmacokinetic screening in drug discovery: comparison of clearance, volume of distribution, half-life, mean residence time, and oral bioavailability obtained by cassette and discrete dosing in rats. J Pharm Sci. 2011;100(9):3862-4. CrossRef
  14. Smith NF, Raynaud FI, Workman P. The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery. Mol Cancer Ther. 2007;6(2):428-0. CrossRef
  15. White RE, Manitpisitkul P. Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metabol Dispos. 2001;29(7):957-6.
  16. Bautista AC, Salimi-Moosavi H, Jawa V. Universal immunoassay applied during early development of large molecules to understand impact of immunogenicity on biotherapeutic exposure. AAPS J. 2012 Sep 1;14(4)843-849.
  17. Ponce R, Abad L, Amaravadi L, Gelzleichter T, Gore E, Green J, / et al. Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies. Regul Toxicol Pharmacol. 2009;54(2):164-2. CrossRef
  18. Chirmule N, Jawa V, Meibohm B. Immunogenicity to therapeutic proteins: impact on PK/PD and efficacy. AAPS J. 2012;14(2):296-02. CrossRef
  19. Hop CE, Wang Z, Chen Q, Kwei G. Plasma-pooling methods to increase throughput for / in vivo pharmacokinetic screening. J Pharm Sci. 1998;87(7):901-. CrossRef
  20. Christ DD. Cassette dosing pharmacokinetics: valuable tool or flawed science? Drug Metabol Dispos. 2001;29(7):935.
  21. He K, Qian M, Wong H, Bai SA, He B, Brogdon B, / et al. N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations. J Pharm Sci. 2008;97(7):2568-0. CrossRef
  22. Mager DE, Jusko WJ. General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Pharmacodyn. 2001;28(6):507-2. CrossRef
  23. Hager JW, Le Blanc JC. High-performance liquid chromatography-tandem mass spectrometry with a new quadrupole/linear ion trap instrument. J Chrom. 2003;1020(1):3-. CrossRef
  24. Hopfgartner G, Varesio E, Tschappat V, Grivet C, Bourgogne E, Leuthold LA. Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules. J Mass Spectrom. 2004;39(8):845-5. CrossRef
  25. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham Cooks R. The Orbitrap: a new mass spectrometer. J Mass Spectrom. 2005;40(4):430-3. CrossRef
  26. Kay RG, Barton C, Velloso CP, Brown PR, Bartlett C, Blazevich AJ, / et al. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Comm Mass Spectrom. 2009;23(19):3173-2. CrossRef
  
• 作者单位：Hongyan Li (1)
  Robert Ortiz (1)
  Linh T. B. Tran (1)
  Hossein Salimi-Moosavi (1)
  Jennifer Malella (1)
  Christopher A. James (1)
  Jean W. Lee (1)
  
  1. Departments of PKDM, Amgen Inc, One Amgen Center Drive, Mail Stop 30E-3-B, Thousand Oaks, California, 91320, USA
  
• ISSN：1550-7416

文摘

We have recently developed a general liquid chromatography-tandem mass spectrometric (LC-MS/MS) method using a stable isotope-labeled (SIL) monoclonal antibody (mAb) as an internal standard (IS) for single-analyte quantification of mAb (Li et al. Anal Chem 84(3):1267-273, 2012). The method offers an advantage over ligand binding assay in reducing the time and resources needed for bioanalytical support in preclinical stages of drug development. In this paper, we report another marked increase in assay efficiency for multi-analyte bioanalysis using unique surrogate peptides for each analyte and the strategic choice of the SIL-IS peptide. The method was qualified for the simultaneous determinations of four mAbs in rat plasma and applied to samples from discrete- and cassette-dosed rats. The pharmacokinetic parameters of the four mAbs of cassette dosing were comparable to those of discrete dosing and of enzyme-linked immunosorbent assay results. Although there may be limitations and special considerations for cassette-dosing of biologics, these results demonstrate the robust performance of the multi-analyte LC-MS/MS method allowing cassette-dosing that would ultimately reduce animal use and improve efficiency.